Home GSK hopes big clinical trial can breathe new life into lung drug
 

Keywords :   


GSK hopes big clinical trial can breathe new life into lung drug

2015-08-13 20:06:52| Biotech - Topix.net

GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result. Data from the so-called SUMMIT study, designed to show GSK's Breo can prolong lives of patients with chronic lung disease, are expected as early as next month, nine years after a similar study with GSK's older drug Advair failed by a whisker.

Tags: life big trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Disruption as airline pilots begin industrial action
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Now is not the time for African swine fever fatigue
26.06Ex-BHS director must pay 50m over firm's collapse
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Pork producers lead coalition against sprinkler mandate
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
More »